AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 17 filers reported holding AMBRX BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,222,775 | -49.3% | 249,190 | -87.1% | 0.21% | -41.9% |
| Q4 2022 | $4,386,982 | +110.2% | 1,932,591 | 0.0% | 0.36% | +61.4% |
| Q3 2022 | $2,087,000 | -59.2% | 1,932,591 | 0.0% | 0.22% | -68.6% |
| Q2 2022 | $5,121,000 | -35.7% | 1,932,591 | 0.0% | 0.71% | +3.3% |
| Q1 2022 | $7,962,000 | -54.4% | 1,932,591 | 0.0% | 0.69% | -31.1% |
| Q4 2021 | $17,451,000 | -33.1% | 1,932,591 | 0.0% | 1.00% | -25.3% |
| Q3 2021 | $26,090,000 | -31.1% | 1,932,591 | 0.0% | 1.34% | -40.6% |
| Q2 2021 | $37,879,000 | – | 1,932,591 | – | 2.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 16,688,636 | $191,919,314 | 67.54% |
| Cormorant Asset Management, LP | 9,923,689 | $114,122,424 | 6.66% |
| COMMODORE CAPITAL LP | 3,518,556 | $40,463,394 | 4.73% |
| Ally Bridge Group (NY) LLC | 281,089 | $3,232,524 | 3.79% |
| Paradigm Biocapital Advisors LP | 3,488,596 | $40,118,854 | 2.72% |
| VR Adviser, LLC | 2,070,000 | $23,805,000 | 2.51% |
| Ghost Tree Capital, LLC | 525,000 | $6,037,500 | 1.99% |
| HighVista Strategies LLC | 193,701 | $2,227,562 | 1.03% |
| Ikarian Capital, LLC | 4,932 | $5,671,800 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 34,000 | $391,000 | 0.51% |